|
FI66878C
(fi)
|
1978-02-24 |
1984-12-10 |
Ciba Geigy Ag |
Foerfarande foer framstaellning av nya antigenderivat
|
|
JPS5528933A
(en)
|
1978-08-21 |
1980-02-29 |
Dai Ichi Seiyaku Co Ltd |
Muramyldipeptide dimer
|
|
JPS5618996A
(en)
|
1979-06-21 |
1981-02-23 |
Dai Ichi Seiyaku Co Ltd |
Muramyldipeptide derivative
|
|
FI75578C
(fi)
|
1979-07-25 |
1988-07-11 |
Ciba Geigy Ag |
Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider.
|
|
JPS58172399A
(ja)
|
1982-04-05 |
1983-10-11 |
Dai Ichi Seiyaku Co Ltd |
ムラミルトリペプチド誘導体
|
|
EP0102319B1
(de)
|
1982-07-23 |
1987-08-19 |
Ciba-Geigy Ag |
Verwendung von Muramylpeptiden oder deren Analogen zur Prophylaxe und Therapie von Virusinfektionen
|
|
ES8609353A1
(es)
|
1984-05-29 |
1986-09-01 |
Ciba Geigy Ag |
Procedimiento para la obtencion de un derivado del azucar
|
|
JPS6157597A
(ja)
|
1984-08-29 |
1986-03-24 |
Toshiyuki Hamaoka |
ムラミルペプチド活性エステル誘導体
|
|
EP0192611A3
(de)
|
1985-02-20 |
1988-05-11 |
Ciba-Geigy Ag |
Acylierte Hexosederivate und Verfahren zu ihrer Herstellung
|
|
EP0192609A3
(de)
|
1985-02-20 |
1988-04-27 |
Ciba-Geigy Ag |
Acylierte Hexosederivate und Verfahren zu ihrer Herstellung
|
|
US4640911A
(en)
|
1985-05-29 |
1987-02-03 |
Ciba-Geigy Corporation |
Acylated sugar derivatives, processes for their manufacture, and their use
|
|
US5540931A
(en)
*
|
1989-03-03 |
1996-07-30 |
Charles W. Hewitt |
Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
|
|
US5549910A
(en)
|
1989-03-31 |
1996-08-27 |
The Regents Of The University Of California |
Preparation of liposome and lipid complex compositions
|
|
JP3218637B2
(ja)
|
1990-07-26 |
2001-10-15 |
大正製薬株式会社 |
安定なリポソーム水懸濁液
|
|
JP2958076B2
(ja)
|
1990-08-27 |
1999-10-06 |
株式会社ビタミン研究所 |
遺伝子導入用多重膜リポソーム及び遺伝子捕捉多重膜リポソーム製剤並びにその製法
|
|
US5506204A
(en)
|
1991-11-19 |
1996-04-09 |
Peptech (Uk) Limited |
Muramyl compounds for treatment of septic shock
|
|
GB9221220D0
(en)
*
|
1992-10-09 |
1992-11-25 |
Sandoz Ag |
Organic componds
|
|
US5349060A
(en)
|
1993-01-07 |
1994-09-20 |
American Home Products Corporation |
Rapamycin 31-ester with N,N-dimethylglycine derivatives useful as immunosuppressive agents
|
|
US5543158A
(en)
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
|
GB9320820D0
(en)
|
1993-10-08 |
1993-12-01 |
Biokine Tech Ltd |
Compounds for medicinal use
|
|
BR9408323A
(pt)
|
1993-12-17 |
1997-08-19 |
Sandoz Ag |
Derivados de rapamicina
|
|
US5741516A
(en)
|
1994-06-20 |
1998-04-21 |
Inex Pharmaceuticals Corporation |
Sphingosomes for enhanced drug delivery
|
|
GB9413935D0
(en)
|
1994-07-11 |
1994-08-31 |
Peptech Uk Ltd |
Use of maramyl peptide compounds
|
|
GB9419011D0
(en)
|
1994-09-21 |
1994-11-09 |
Peptech Uk Ltd |
Use of muramyl peptide compounds
|
|
US5795587A
(en)
|
1995-01-23 |
1998-08-18 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
|
DE69624921T2
(de)
|
1995-06-09 |
2003-09-11 |
Novartis Ag, Basel |
Rapamycinderivate
|
|
US5738868A
(en)
|
1995-07-18 |
1998-04-14 |
Lipogenics Ltd. |
Liposome compositions and kits therefor
|
|
GB9618673D0
(en)
|
1996-09-06 |
1996-10-16 |
Peptech Uk Ltd |
The use of muramyl peptides
|
|
EP1278542A2
(en)
|
2000-05-05 |
2003-01-29 |
Cytos Biotechnology AG |
Molecular antigen arrays and vaccines
|
|
CA2319928A1
(en)
|
2000-09-18 |
2002-03-18 |
Vasogen Ireland Limited |
Apoptosis-mimicking synthetic entities and use thereof in medical treatments
|
|
GB0025414D0
(en)
|
2000-10-16 |
2000-11-29 |
Consejo Superior Investigacion |
Nanoparticles
|
|
US7592008B2
(en)
|
2000-11-20 |
2009-09-22 |
The Board Of Trustees Of The University Of Illinois, A Body Corporate And Politic Of The State Of Illinois |
Membrane scaffold proteins
|
|
EP1456652A4
(en)
|
2001-11-13 |
2005-11-02 |
Dana Farber Cancer Inst Inc |
IMMUNOCELL ACTIVATION MODULATING SUBSTANCES AND USE METHOD THEREFOR
|
|
ES2367430T3
(es)
|
2002-12-23 |
2011-11-03 |
Wyeth Llc |
Anticuerpos contra pd-1 y sus usos.
|
|
CN101675993A
(zh)
|
2003-03-26 |
2010-03-24 |
赛托斯生物技术公司 |
Melan-a肽类似物-病毒样颗粒偶联物
|
|
WO2005101466A2
(en)
|
2003-12-19 |
2005-10-27 |
The University Of North Carolina At Chapel Hill |
Methods for fabricating isolated micro- and nano- structures using soft or imprint lithography
|
|
KR20070015544A
(ko)
|
2004-04-14 |
2007-02-05 |
와이어쓰 |
라파마이신 42-에스테르 유도체의 위치특이성 합성
|
|
KR100560102B1
(ko)
|
2004-06-25 |
2006-03-13 |
한국생명공학연구원 |
프로아포리포단백질 a-ⅰ 변이체와, 이를 포함하는고지혈증 또는 동맥경화증 예방 및 치료제
|
|
WO2006080951A2
(en)
|
2004-07-01 |
2006-08-03 |
Yale University |
Targeted and high density drug loaded polymeric materials
|
|
US20060134189A1
(en)
|
2004-11-17 |
2006-06-22 |
Protiva Biotherapeutics, Inc |
siRNA silencing of apolipoprotein B
|
|
EP3530736A3
(en)
|
2005-05-09 |
2019-11-06 |
ONO Pharmaceutical Co., Ltd. |
Human monoclonal antibodies to programmed death 1 (pd-1) and methods for treating cancer using anti-pd-1 antibodies alone or in combination with other immunotherapeutics
|
|
KR101704734B1
(ko)
|
2005-07-01 |
2017-02-09 |
이. 알. 스퀴부 앤드 선즈, 엘.엘.씨. |
예정 사멸 리간드 1 (피디-엘1)에 대한 인간 모노클로날 항체
|
|
EP1926372A2
(en)
|
2005-08-19 |
2008-06-04 |
Cylene Pharmaceuticals, Inc. |
HUMAN RIBOSOMAL DNA(rDNA) AND RIBOSOMAL RNA (rRNA) NUCLEIC ACIDS AND USES THEREOF
|
|
US20090226525A1
(en)
|
2007-04-09 |
2009-09-10 |
Chimeros Inc. |
Self-assembling nanoparticle drug delivery system
|
|
CN101096386A
(zh)
|
2007-06-05 |
2008-01-02 |
复旦大学 |
Dectin-1与热休克蛋白Hsp60聚合物及其编码核酸和应用
|
|
PT2170959E
(pt)
|
2007-06-18 |
2014-01-07 |
Merck Sharp & Dohme |
Anticorpos para o receptor humano de morte programada pd-1
|
|
KR101601332B1
(ko)
|
2007-10-05 |
2016-03-08 |
센화 바이오사이언시즈 인코포레이티드 |
퀴놀론 유사체 및 이와 관련된 방법
|
|
MX2010003642A
(es)
|
2007-10-12 |
2010-08-09 |
Massachusetts Inst Technology |
Nanotecnologia de vacuna.
|
|
EP2217221B1
(en)
|
2007-10-17 |
2018-06-27 |
Korea Advanced Institute of Science and Technology |
Ldl-like cationic nanoparticles for deliverying nucleic acid gene, method for preparing thereof and method for deliverying nucleic acid gene using the same
|
|
US20110020242A1
(en)
|
2007-12-12 |
2011-01-27 |
Gang Zheng |
High-density lipoprotein-like peptide-phospholipid scaffold ("hpps") nanoparticles
|
|
WO2009106999A2
(en)
|
2008-02-28 |
2009-09-03 |
Deutsches Krebsforschungszentrum, Stiftung Des Öffentlichen Rechts |
Hollow nanoparticles and uses thereof
|
|
US8168757B2
(en)
|
2008-03-12 |
2012-05-01 |
Merck Sharp & Dohme Corp. |
PD-1 binding proteins
|
|
US8268796B2
(en)
|
2008-06-27 |
2012-09-18 |
Children's Hospital & Research Center At Oakland |
Lipophilic nucleic acid delivery vehicle and methods of use thereof
|
|
WO2010036959A2
(en)
|
2008-09-26 |
2010-04-01 |
Dana-Farber Cancer Institute |
Human anti-pd-1, pd-l1, and pd-l2 antibodies and uses therefor
|
|
WO2010048452A2
(en)
|
2008-10-22 |
2010-04-29 |
Kathryn Jill Chavez |
Polycyclic compounds and methods related thereto
|
|
WO2010047839A1
(en)
|
2008-10-25 |
2010-04-29 |
Aura Biosciences |
Modified plant virus particles and uses therefor
|
|
MX356367B
(es)
|
2008-12-09 |
2018-05-25 |
Genentech Inc |
Anticuerpos anti-pd-l1 y su uso para mejorar la funcion de celulas t.
|
|
WO2010089411A2
(en)
|
2009-02-09 |
2010-08-12 |
Universite De La Mediterranee |
Pd-1 antibodies and pd-l1 antibodies and uses thereof
|
|
US9051567B2
(en)
|
2009-06-15 |
2015-06-09 |
Tekmira Pharmaceuticals Corporation |
Methods for increasing efficacy of lipid formulated siRNA
|
|
WO2011044545A2
(en)
*
|
2009-10-09 |
2011-04-14 |
Sigalov Alexander B |
Methods and compositions for targeted imaging
|
|
EP2504028A4
(en)
|
2009-11-24 |
2014-04-09 |
Amplimmune Inc |
SIMULTANEOUS INHIBITION OF PD-L1 / PD-L2
|
|
US20130022629A1
(en)
|
2010-01-04 |
2013-01-24 |
Sharpe Arlene H |
Modulators of Immunoinhibitory Receptor PD-1, and Methods of Use Thereof
|
|
US9163087B2
(en)
|
2010-06-18 |
2015-10-20 |
The Brigham And Women's Hospital, Inc. |
Bi-specific antibodies against TIM-3 and PD-1 for immunotherapy in chronic immune conditions
|
|
US8907053B2
(en)
|
2010-06-25 |
2014-12-09 |
Aurigene Discovery Technologies Limited |
Immunosuppression modulating compounds
|
|
PL2620156T3
(pl)
|
2010-08-23 |
2019-10-31 |
Kang Stem Biotech Co Ltd |
Kompozycja farmaceutyczna do zapobiegania lub leczenia chorób immunologicznych lub chorób zapalnych, zawierająca komórki macierzyste traktowane agonistą NOD2 lub jego produktem hodowlanym
|
|
KR101253399B1
(ko)
|
2010-10-26 |
2013-04-11 |
영남대학교 산학협력단 |
아포지단백질 a-i 및 그 변이체를 포함한 재조합 고밀도지단백질을 이용한 라파마이신 제형
|
|
WO2012123938A1
(en)
|
2011-03-17 |
2012-09-20 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Quinolone analogs for treating autoimmune diseases
|
|
CN102178954B
(zh)
|
2011-04-25 |
2014-05-28 |
中国药科大学 |
具有血管壁靶向和逆向转运胆固醇功能的重组高密度脂蛋白载药系统及其应用
|
|
WO2013143555A1
(en)
|
2012-03-26 |
2013-10-03 |
Biontech Ag |
Rna formulation for immunotherapy
|
|
WO2013192310A1
(en)
*
|
2012-06-19 |
2013-12-27 |
Massachusetts Institute Of Technology |
Mass production and size control of nanoparticles through controlled microvortices
|
|
EP2703384A1
(en)
|
2012-08-27 |
2014-03-05 |
Ludwig-Maximilians-Universität München |
Inhibitors of CD40-TRAF6 interaction
|
|
CN103589699B
(zh)
|
2013-11-05 |
2015-05-13 |
江南大学 |
一种可溶性淀粉底物特异性提高的环糊精糖基转移酶
|
|
EA201690912A1
(ru)
|
2013-11-05 |
2016-10-31 |
Когнейт Биосервисис, Инк. |
Комбинации ингибиторов контрольных точек и терапевтических средств для лечения рака
|
|
EP3074391B1
(en)
|
2013-11-28 |
2019-07-31 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Rna polymerase i inhibitors and uses thereof
|
|
HRP20220070T1
(hr)
|
2014-04-23 |
2022-04-01 |
Modernatx, Inc. |
Cjepiva nukleinske kiseline
|
|
WO2016019333A1
(en)
|
2014-07-31 |
2016-02-04 |
Kinemed, Inc. |
The effect of phospholipid composition of reconstituted hdl on its cholesterol efflux and anti-inflammatory properties
|
|
WO2016138286A1
(en)
|
2015-02-26 |
2016-09-01 |
Stc.Unm |
Irgm and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy
|
|
AU2016238290B9
(en)
|
2015-03-25 |
2019-06-13 |
The Regents Of The University Of Michigan |
Compositions and methods for delivery of biomacromolecule agents
|
|
US11642419B2
(en)
|
2015-03-25 |
2023-05-09 |
The Regents Of The University Of Michigan |
Compositions and methods for treating cardiovascular related disorders
|
|
WO2016155809A1
(en)
|
2015-03-31 |
2016-10-06 |
Biontech Rna Pharmaceuticals Gmbh |
Lipid particle formulations for delivery of rna and water-soluble therapeutically effective compounds to a target cell
|
|
US20180140725A1
(en)
|
2015-04-20 |
2018-05-24 |
Memorial Sloan Kettering Cancer Center |
Imaging of tumor-associated macrophages
|
|
WO2016172615A1
(en)
|
2015-04-24 |
2016-10-27 |
University Of Delaware |
Synthetic n-acetyl-muramic acid derivatives and uses thereof
|
|
US10995140B2
(en)
|
2015-06-05 |
2021-05-04 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
GM-CSF/CD40L vaccine and checkpoint inhibitor combination therapy
|
|
SG10201912394VA
(en)
|
2015-07-15 |
2020-02-27 |
Celator Pharmaceuticals Inc |
Improved nanoparticle delivery systems
|
|
US20180221289A1
(en)
|
2015-08-06 |
2018-08-09 |
Autotelic Llc |
Phospholipid-cholesteryl ester nanoformulations and related methods
|
|
EP3389635A4
(en)
*
|
2015-12-18 |
2019-08-07 |
Northwestern University |
STAIN OXIDE-RELATED NANOPARTICLES OF SIMILARITY WITH HIGH-DENSITY LIPOPROTEINS
|
|
US20190008918A1
(en)
|
2016-03-08 |
2019-01-10 |
Bioxcel Corporation |
Immunomodulation therapies for cancer
|
|
WO2017190145A1
(en)
*
|
2016-04-29 |
2017-11-02 |
Icahn School Of Medicine At Mount Sinai |
Targeting the innate immune system to induce long-term tolerance and to resolve macrophage accumulation in atherosclerosis
|
|
WO2017205536A2
(en)
|
2016-05-24 |
2017-11-30 |
Genentech, Inc. |
Therapeutic compounds and uses thereof
|
|
WO2018071549A1
(en)
|
2016-10-11 |
2018-04-19 |
New York University |
Nanoparticles and uses thereof
|
|
CN106831614B
(zh)
|
2017-01-09 |
2020-07-28 |
清华大学 |
取代的苯并二氮杂环类化合物及其制备方法和用途
|
|
JP2020515629A
(ja)
|
2017-04-04 |
2020-05-28 |
アヴィディア テクノロジーズ, インコーポレイテッド |
免疫応答を誘導するためのペプチドベースのワクチン、それらの製造方法および使用
|
|
JP7357629B2
(ja)
|
2017-11-20 |
2023-10-06 |
アイカーン スクール オブ メディスン アット マウント サイナイ |
治療用ナノバイオロジー組成物での訓練された免疫の阻害
|
|
JP7330994B2
(ja)
|
2017-11-21 |
2023-08-22 |
アイカーン スクール オブ メディスン アット マウント サイナイ |
治療用ナノ生物学的組成物による訓練免疫の促進
|
|
KR102198900B1
(ko)
|
2019-05-10 |
2021-01-07 |
서강대학교 산학협력단 |
질병 치료용 나노입자 복합체 및 이의 제조방법
|
|
CN118459539B
(zh)
|
2021-03-19 |
2026-01-06 |
生物治疗探索股份有限公司 |
用于调节训练免疫的化合物及其使用方法
|
|
WO2023192956A2
(en)
|
2022-03-31 |
2023-10-05 |
Icahn School Of Medicine At Mount Sinai |
Sphingolipid-loaded nanobiologics for immune regulation
|